American Rafarma Pharmaceuticals, Inc. plans to produce medici | Emb of Uzbekistan to EU & Benelux
American Rafarma Pharmaceuticals, Inc. plans to produce medicines for use by public health institutions in the Tashkent Pharma Park. Projected costs are currently at $82 millions for 2021-2025.
Subscribe to Uzbekistan and EU news channel Website: http://belgium.mfa.uz/. Facebook:https://www.facebook.com/UzEmbBenelux. Twitter:https://twitter.com/UzEmBenelux. Odnoklassniki: ok.ru/posolstvo.uzb...